This company seems to have been delisted
Reason: Rebranded as Artivion (AORT)
Source: https://www.prnewswire.com/news-releases/cryolife-announces-corporate-rebranding-and-changes-name-to-artivion-301462581.html
Reason: Rebranded as Artivion (AORT)
Source: https://www.prnewswire.com/news-releases/cryolife-announces-corporate-rebranding-and-changes-name-to-artivion-301462581.html
CryoLife
CRY
₹1,528
Share price
1.42%
Change (1 day)
-19.63%
Change (1 year)
Categories
Revenue for CryoLife (CRY)
Revenue in 2021 (TTM): ₹22.15 Billion
According to CryoLife's latest financial reports the company's current revenue is ₹25.54 Billion. In 2020 the company made a revenue of ₹21.64 Billion a decrease over the revenue in the year 2019 that were of ₹23.61 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for CryoLife from 2001 to 2021
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2021 (TTM) | ₹22.15 B | 2.34% |
| 2020 | ₹21.64 B | -8.32% |
| 2019 | ₹23.61 B | 5.09% |
| 2018 | ₹22.46 B | 38.55% |
| 2017 | ₹16.21 B | 5.17% |
| 2016 | ₹15.41 B | 23.63% |
| 2015 | ₹12.47 B | 0.87% |
| 2014 | ₹12.36 B | 2.81% |
| 2013 | ₹12.02 B | 7.32% |
| 2012 | ₹11.20 B | 9.59% |
| 2011 | ₹10.22 B | 2.56% |
| 2010 | ₹9.97 B | 4.12% |
| 2009 | ₹9.57 B | 6.64% |
| 2008 | ₹8.98 B | 10.87% |
| 2007 | ₹8.10 B | 16.54% |
| 2006 | ₹6.95 B | 17.36% |
| 2005 | ₹5.92 B | 11.06% |
| 2004 | ₹5.33 B | 4.79% |
| 2003 | ₹5.08 B | -23.48% |
| 2002 | ₹6.65 B | -11.26% |
| 2001 | ₹7.49 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | ₹1.098 T | 4,202.03% | 🇺🇸 USA |
 | ₹489.32 B | 1,815.53% | 🇺🇸 USA |
 | ₹2.837 T | 11,009.44% | 🇮🇪 Ireland |
 | ₹1.931 T | 7,461.00% | 🇺🇸 USA |
 | ₹137.67 B | 438.93% | 🇺🇸 USA |
 | ₹1.431 T | 5,503.74% | 🇺🇸 USA |
 | ₹260.49 B | 919.73% | 🇺🇸 USA |
 | ₹7.592 T | 29,622.32% | 🇺🇸 USA |